These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32534438)

  • 1. Characteristic of gut microbiota in southeastern Chinese patients with neuromyelitis optica spectrum disorders.
    Zhang J; Xu YF; Wu L; Li HF; Wu ZY
    Mult Scler Relat Disord; 2020 Sep; 44():102217. PubMed ID: 32534438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: A cross sectional study.
    Shi Z; Qiu Y; Wang J; Fang Y; Zhang Y; Chen H; Du Q; Zhao Z; Yan C; Yang M; Zhou H
    J Neuroimmunol; 2020 Feb; 339():577126. PubMed ID: 31841737
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Pandit L; Cox LM; Malli C; D'Cunha A; Rooney T; Lokhande H; Willocq V; Saxena S; Chitnis T
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33148687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Gut Microbiota in Neuromyelitis Optica Spectrum Disorder.
    Yao SQ; Yang X; Cen LP; Tan S
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of short-chain fatty acids and overgrowth of opportunistic pathogens define dysbiosis of neuromyelitis optica spectrum disorders: A Chinese pilot study.
    Gong J; Qiu W; Zeng Q; Liu X; Sun X; Li H; Yang Y; Wu A; Bao J; Wang Y; Shu Y; Hu X; Bellanti JA; Zheng SG; Lu Y; Lu Z
    Mult Scler; 2019 Aug; 25(9):1316-1325. PubMed ID: 30113252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab-induced gut microbiota changes in Chinese neuromyelitis optica spectrum disorders.
    Chen H; Xu Z; Zhou Y; Jiang YH; Chen J; Xiong Y; Zhou M; Wu X; Hong D
    Mult Scler Relat Disord; 2024 Jun; 86():105606. PubMed ID: 38636269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Barrier Breakdown and Mucosal Microbiota Disturbance in Neuromyelitis Optical Spectrum Disorders.
    Cui C; Tan S; Tao L; Gong J; Chang Y; Wang Y; Fan P; He D; Ruan Y; Qiu W
    Front Immunol; 2020; 11():2101. PubMed ID: 32983166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of the gut microbiota in neuromyelitis optica spectrum disorder: Implication for intervention.
    Cui C; Ruan Y; Qiu W
    J Clin Neurosci; 2020 Dec; 82(Pt B):193-199. PubMed ID: 33257156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the 2015 neuromyelitis optica spectrum disorders diagnostic criteria in a cohort of Chinese patients.
    He M; Wu L; Huang D; Yu S
    Mult Scler Relat Disord; 2020 Nov; 46():102459. PubMed ID: 32853894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
    Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
    Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of gastrointestinal toxicity in neuromyelitis optica spectrum disorder patients treated with mycophenolate mofetil: insights from a mouse model and human study.
    Li G; Xia L-J; Shu Y-Q; Wan L; Huang Q; Ma X-Y; Zhang H-Y; Zheng Z-J; Wang X-R; Zhou S-Y; Gao A; Ren H; Lian X-L; Xu D; Tang S-Q; Liao X-P; Qiu W; Sun J
    Microbiol Spectr; 2024 Aug; 12(8):e0430723. PubMed ID: 38916339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of purine metabolites and gut microbiota in patients with neuromyelitis optica spectrum disorders after mycophenolate mofetil treatment.
    Li G; Ma X; Xia L; Wei R; Wang X; Li C; Wang Y; He L; Ren H; Sun J; Qiu W
    BMC Neurol; 2023 Dec; 23(1):444. PubMed ID: 38102573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common genetic variants in PRRC2A are associated with both neuromyelitis optica spectrum disorder and multiple sclerosis in Han Chinese population.
    Zhang J; Chen MJ; Zhao GX; Li HF; Wu L; Xu YF; Liao Y; Yuan Z; Wu ZY
    J Neurol; 2021 Feb; 268(2):506-515. PubMed ID: 32862241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Actual issues of serum aquaporin-4 autoantibodies evaluation in the diagnostics of neuromyelitis optica spectrum disorders].
    Krasnov VS; Totolyan NA; Nazarov VD; Mazing AV; Makshakov GS; Lapin SV; Evdoshenko EP; Skoromets AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):24-31. PubMed ID: 32844626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GV-971 attenuates the progression of neuromyelitis optica in murine models and reverses alterations in gut microbiota and associated peripheral abnormalities.
    Yang X; Zhangyi Z; Yu A; Zhou Q; Xia A; Qiu J; Cai M; Chu X; Li L; Feng Z; Luo Z; Sun G; Zhang J; Geng M; Chen S; Xie Z
    CNS Neurosci Ther; 2024 Jul; 30(7):e14847. PubMed ID: 38973196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
    Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
    J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
    Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid lactate level in aquaporin-4 antibody positive neuromyelitis optica spectrum disorders: a hint on differential diagnosis and possible immunopathogenesis.
    Wang N; Zhang SN; Xing RJ; Liu MQ; Huang CN; Jiang SM; Li T; Yang CS; Yang L; Zhang LJ
    Mult Scler Relat Disord; 2021 Jan; 47():102629. PubMed ID: 33232908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
    Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
    Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of inflammation in neuromyelitis optica spectrum disorders.
    Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
    Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.